本页面由Tiger Trade Technology Pte. Ltd.提供服务

Chemomab Therapeutics Ltd.

2.16
+0.09004.35%
盘后2.12-0.0400-1.85%16:10 EDT
成交量:11.42万
成交额:24.26万
市值:1,582.78万
市盈率:-2.15
高:2.20
开:2.06
低:2.04
收:2.07
52周最高:4.12
52周最低:1.35
股本:732.77万
流通股本:614.41万
量比:2.02
换手率:1.86%
股息:- -
股息率:- -
每股收益(TTM):-1.0070
每股收益(LYR):-1.4103
净资产收益率:-82.17%
总资产收益率:-46.27%
市净率:1.82
市盈率(LYR):-1.53

数据加载中...

2026/08/13

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/10

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/23

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/29

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/21

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/04

SEC问询函

Form CORRESP - Correspondence
2024/08/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/03/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/02

SEC问询函

Form CORRESP - Correspondence
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/05

重要事件披露

Form 8-K - Current report
2023/05/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/03/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933